Teresa Martínez-Menchón

Summary

Country: Spain

Publications

  1. ncbi Phacomatosis pigmentokeratotica: a 20-year follow-up with malignant degeneration of both nevus components
    Teresa Martínez-Menchón
    Service of Dermatology, Valencia University General Hospital, Valencia, Spain
    Pediatr Dermatol 22:44-7. 2005
  2. ncbi [Treatment of severe refractory psoriasis with infliximab]
    Laura Mahiques Santos
    Servicio de Dermatologia y Venereologia, Hospital General Universitario, Valencia, Spain
    Med Clin (Barc) 123:657-8. 2004
  3. ncbi [Refractory psoriasis treatment with etanercept]
    Laura Mahiques Santos
    Servicio de Dermatologia y Venereologia, Hospital General Universitario de Valencia, Valencia, Spain
    Med Clin (Barc) 125:371-3. 2005

Detail Information

Publications3

  1. ncbi Phacomatosis pigmentokeratotica: a 20-year follow-up with malignant degeneration of both nevus components
    Teresa Martínez-Menchón
    Service of Dermatology, Valencia University General Hospital, Valencia, Spain
    Pediatr Dermatol 22:44-7. 2005
    ..This observation, in concert with the other instances reported in the literature, points to the need for adequate patient follow-up to ensure early detection and treatment of any possible associated malignant degeneration...
  2. ncbi [Treatment of severe refractory psoriasis with infliximab]
    Laura Mahiques Santos
    Servicio de Dermatologia y Venereologia, Hospital General Universitario, Valencia, Spain
    Med Clin (Barc) 123:657-8. 2004
    ..Infliximab is a chimeric monoclonal antibody that binds to tumor necrosis factor alpha and blocks the inflammatory response. The purpose of this study was to assess the effects of infliximab in patients with severe and refractory psoriasis...
  3. ncbi [Refractory psoriasis treatment with etanercept]
    Laura Mahiques Santos
    Servicio de Dermatologia y Venereologia, Hospital General Universitario de Valencia, Valencia, Spain
    Med Clin (Barc) 125:371-3. 2005
    ..The purpose of this study was to assess the effects of etanercept and its maintenance in patients with severe and refractory psoriasis...